Putting AI on the Bench for Cross-Organ Fibrosis Drug Development
1:30 pm - Wednesday 2nd December 2026
- Evaluating the rationale for artificial intelligence (AI)-enabled pan-fibrotic development approaches
- Discussing failures and successes of human-in-the-loop AI to prioritize cross-organ fibrosis drug targets and patient-relevant wet lab target validation at scale
